How to cite item

Bevacizumab in recurrent glioblastoma

   
@article{TCR26303,
	author = {Nina L. Martinez and Jon Glass and Wenyin Shi},
	title = {Bevacizumab in recurrent glioblastoma},
	journal = {Translational Cancer Research},
	volume = {8},
	number = {Suppl 2},
	year = {2019},
	keywords = {},
	abstract = {In May 2009, the U.S. Food and Drug Administration granted accelerated approval for the use of bevacizumab in patients with progressive glioblastoma (GBM), the most common malignant primary brain tumor in  adults (1). Neovascularization is a morphologic hallmark of GBM, driven in part by vascular endothelial growth factor A (VEGF-A) which is targeted and neutralized by bevacizumab.},
	issn = {2219-6803},	url = {https://tcr.amegroups.org/article/view/26303}
}